" />
Skip to main content
Navigate Up
Sign In

Mucosal and Vaccine Research Colorado

MAVRC Pilot Award Funds in Human Immunbiology



2009 MAVRC Pilot Fund Awardees

MAVRC is proud to announce the Awardees of the 2009 MAVRC Pilot Funds for Human Immunobiology Studies. Congratulations to the recipients of the two $25,000 awards for innovative and collaborative research projects to explore mucosal and vaccine biology. 


 Photo-Dr. Adit Ginde

    Dr. Adit Ginde


Vitamin D Supplementation and Varicella Zoster Virus Vaccine Responsiveness in Older Nursing Home Residents


PI:  Adit A. Ginde, MD, MPH; Assistant Professor of Surgery

Co-I:  Myron J. Levin, MD; Professor of Pediatrics

Co-I:  Robert S. Schwartz, MD; Professor of Medicine


J. David Beckham, MD - Photo

Dr. David Beckham


Cytokine Biomarkers in Patients with Central Nervous System Infections


PI:  J. David Beckham, MD; Associate Professor of Infectious Diseases

Co-I:  Kenneth L. Tyler, MD; Professor of Neurology, Infectious

               Diseases, and Microbiology

Co-I:  Charles A. Dinarello, MD; Professor of Infectious Diseases


The Mucosal and Vaccine Research Colorado (MAVRC) program is soliticing applications for pilot award funding for collaborative human immunobiology studies. MAVRC promotes new interactions between a diverse spectrum of researchers to explore mucosal and vaccine biology and disease. Our goal is to foster and facilitate the development of innovative collaborative, interdisciplinary biomedical research programs in human mucosal biology, immunology and vaccine development.



Applicant teams will include basic and clinical faculty investigators, with an emphasis on new interdepartmental or inter-institutional collaborations. Academic researchers must become MAVRC members in order to apply. To access the simple application, click the "Join MAVRC" button on webpage http://medschool.ucdenver.edu/MAVRC. A free membership entitles you to access to pilot funding opportunities, administrative support for new research and funding, shared sponsorship for speakers, and participation in a statewide collaborative research network.

Proposals will represent new and creative projects investigating human immunobiology, supported by a concrete plan for specific subsequent external funding. Submissions will be reviewed by the MAVRC Board of Directors for significance, innovation, approach, and budget. Relevant IRB approval must be attained prior to the award allocation.

Two innovative pilot projects will be selected to receive a $25,000 award for studies to be conducted within a one year period, with no carryover. The awards will cover direct costs only, including supplies, (non Principal Investigator) salaries, patient costs, and should not supplement other grants.



Applications are due September 15, 2009 in pdf form emailed to MAVRC@ucdenver.edu. A three-page proposal (covering numbers 2-6; Arial 11 font) in NIH format will include:

1.      Cover page (Title and Investigators)

2.      Hypotheses

3.      Specific Objectives

4.      Background, including special significance

5.      Work proposed

6.      Plan for subsequent funding

7.      IRB plan for protection of human subjects (approval due prior to funding)

8.      Budget (direct costs only; no indirect costs provided) (one page)

9.      NIH biosketch of each Investigator



Notification of Awards

Selected awardees will be announced October 15, 2009. Brief summary statements will be provided. Funding commences with IRB approval.


Scientific Inquires:

Edward Janoff, MD-Director


Administrative Inquires:

Diane Strong, MBA-Administrator



  Mucosal and Vaccine Research Colorado

  12631 East 17th Avenue, Suite 7408 • Mail Stop 8205 • Aurora, CO 80045

Program Administrator:  Carola Hagenau  Phone: 303-724-8499 • Fax: 303-724-0802 • E-mail: MAVRC@ucdenver.edu                           

  http://ucdenver.edu/MAVRC • DirectionsVisitor Parking Map                              Executive Director: Edward N. Janoff, MD   


© The Regents of the University of Colorado, a body corporate. All rights reserved.

Accredited by the Higher Learning Commission. All trademarks are registered property of the University. Used by permission only.